Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy.

[1]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[2]  N. Lakkis,et al.  Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis. , 2009, European heart journal.

[3]  M. Gold,et al.  Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[4]  N. Smedira,et al.  Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation. , 2008, JACC. Cardiovascular interventions.

[5]  B. Gersh,et al.  Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy , 2008, Circulation.

[6]  U. Sigwart.  Catheter treatment for hypertrophic obstructive cardiomyopathy: for seniors only? , 2008, Circulation.

[7]  L. Trinquart,et al.  Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. , 2008, European heart journal.

[8]  T. Türk,et al.  Treatment modalities in hypertrophic obstructive cardiomyopathy: surgical myectomy versus percutaneous septal ablation. , 2007, The heart surgery forum.

[9]  K. Smith,et al.  Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation. , 2007, The American journal of cardiology.

[10]  L. Faber,et al.  Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy , 2007, Clinical Research in Cardiology.

[11]  S. Ommen,et al.  Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial? , 2007, Journal of the American College of Cardiology.

[12]  M. Quiñones,et al.  Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[13]  Mario J. Garcia,et al.  Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy , 2007, Heart.

[14]  C. Stellbrink,et al.  Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[15]  A. Tajik,et al.  Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[16]  H. Lever.  Selection of hypertrophic cardiomyopathy patients for myectomy or alcohol septal ablation. , 2006, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[17]  M. Link,et al.  Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2006, Circulation.

[18]  I. Palacios,et al.  Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy. , 2006, The American journal of cardiology.

[19]  P. Boekstegers,et al.  Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. , 2005, Zeitschrift fur Kardiologie.

[20]  P. Serruys,et al.  Percutaneous Versus Surgical Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy and Enlarged Anterior Mitral Valve Leaflets , 2005, Circulation.

[21]  S. Nagueh,et al.  A prospective follow‐up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy—The baylor experience (1996–2002) , 2005, Clinical cardiology.

[22]  W. Williams,et al.  Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. , 2005, The Journal of thoracic and cardiovascular surgery.

[23]  A. Tajik,et al.  Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. , 2004, Journal of the American College of Cardiology.

[24]  Q. Lu,et al.  Transcoronary ablation of septal hypertrophy compared with surgery in the treatment of hypertrophic obstructive cardiomyopathy. , 2004, Chinese medical journal.

[25]  N. Smedira,et al.  Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. , 2004, The American journal of cardiology.

[26]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[27]  B. Maron,et al.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[28]  M. S. Hamid,et al.  Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. , 2002, European heart journal.

[29]  M. Kern,et al.  Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[30]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[31]  N. Smedira,et al.  Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. , 2002, Journal of the American College of Cardiology.

[32]  J. K. Dunn,et al.  Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. , 2000, Journal of the American College of Cardiology.

[33]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[34]  J. Cutler,et al.  Variance imputation for overviews of clinical trials with continuous response. , 1992, Journal of clinical epidemiology.

[35]  W. Williams,et al.  Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making. , 1992, Journal of the American College of Cardiology.

[36]  N. Smedira,et al.  Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. , 2008, The Annals of thoracic surgery.